Exploring a potential novel marker for short-term mortality in decompensated cirrhosis: insights from a multicentre study
The dMLR is independently associated with 90-day mortality in patients with DLC, with an increasing risk of death corresponding to higher dMLR values. dMLR may function as a simple, cost-effective, and reliable biomarker, assisting clinicians in identifying high-risk patients and may guide risk stratification and management.
Authors
- Guixiang Wang (ORCID: https://orcid.org/0000-0002-7404-0131)
- Chiyi He (ORCID: https://orcid.org/0000-0002-5648-840X)
- Honglei Ju
- Jin Cheng
- Wei Wang
Institutions
- Wannan Medical College (CN)
- People's Hospital of Bishan District (CN)
- First Affiliated Hospital of Wannan Medical College (CN)
- Anhui University of Technology (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1080/07853890.2025.2570799
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00